Skip to content

Visia AF™

by Medtronic, Inc. 2 variants

Ref DVAC3D1

Visia AF™ (DVAC3D1) is a device classified as Active implantable (AIMDD) made by Medtronic, Inc., registered in EUDAMED on 26 Aug 2026 (Basic UDI-DI B-00763000052713), active as of 24 Oct 2026.

Active European Union

CE AIMDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 24 Oct 2026.

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/AIMDD NumberB-00763000052713 Basic UDI-DI Date26 Aug 2026RegisteredStatusActive

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/AIMDD Active

Specification

EUDAMED

Device name
Evera,Visia AF, Primo/Mirro w MRI
Model / reference
DVAC3D1
Primary DI / UDI-DI
00763000052713, 00643169566392
Basic UDI-DI
B-00763000052713, B-00643169566392
EMDN code
J01050101 Implantable single chamber defibrillators, with sensors
Device class
Class AIMDD
EU registration type
Legacy device (under a directive)
EU market of registration
Netherlands

Manufacturer details

EUDAMED SRN
US-MF-000019977
Authorised representative
Medtronic B.V. NL-AR-000006050

Similar devices in this category

Other devices filed under CARDIAC FUNCTIONALITY IMPLANTABLE DEVICES.

Other devices from Medtronic, Inc.

See all devices from Medtronic, Inc. →

Properties

  • Supplied sterile
  • Implantable
Other properties (12, all answered No)